![](/img/cover-not-exists.png)
LXR inverse agonists inhibit de novo lipogenesis and reduce intestinal lipid and cholesterol absorption in a NAFLD mouse model
Kremoser, C., Deuschle, U., Gege, C., Kinzel, O., Krol, H.D., Albers, M., Birkel, M., Hambruch, E.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)30929-2
Date:
April, 2018
File:
PDF, 179 KB
english, 2018